All News

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

The 4th of July is a great time to celebrate with family and friends.

Better Care Reconciliation Act would structure subsidies differently than the American Health Care Act.

Part of the FDA's actions focuses on expediting review of generic applications.

More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.

The new tool aims to help patients make more informed treatment decisions and manage expectations following a cancer diagnosis.

Finding ways to triage patients and identify those with the greatest need is important.

Pharmacists working in eastern North Carolina counties have developed a program to improve immunization among low income, uninsured patients.

Lowering systolic blood pressure can reduce the risk of cardiovascular disease and mortality.

Combining oncolytic virotherapy with PD-1 blockades shows promise treating rhabdomyosarcoma.

The tool can help reduce the cost of treatment for rheumatoid arthritis.

Study suggests importance for individuals to get yearly flu shots.

Top news of the day from across the health care landscape.

Patients with type 2 diabetes who do not take insulin may not require fingerstick testing.

Top news of the day from across the healthcare landscape.

“National trends in prescription drug expenditures and projections for 2017,” highlights total US prescription sales for the 2016 calendar year.

Summer has begun, and people must be more cautious of their surroundings when going outdoors.

Despite recent concerns about proton pump inhibitor (PPI) safety, a recently-published study found no evidence that PPI use contributes to a higher risk of dementia or Alzheimer’s disease in older adults.

In entering into these types of arrangements with physicians, the pharmacy must avoid violating the Medicare anti-kickback statute (“AKS”) and the federal Stark physician self-referral statute (“Stark”).

Drug development and innovation could render the current specialty pharmacy model obsolete in 20 years.

The FDA has created a list of off-patent drugs with no generics and plans to expedite drug approvals.

Investigational drug demonstrates a substantial and clinically meaningful reduction in bleeds related to hemophilia.

Is the onus for opioid addiction drug manufacturers or patients who misuse these drugs?

The National HIV Testing Day annual campaign takes place on June 27th.

Nilotinib (Tasigna) may lead to treatment-free remission among certain patients with chronic myeloid leukemia.

Type 2 diabetes could result from beta cells becoming immature and not properly functioning.

Data suggests favorable tolerability of novel treatment in patients with relapsed or refractory AML.

Rational design approaches could transform how multiple sclerosis is treated.

Erelzi (etanercept) indicated to treat multiple inflammatory conditions.